Industry News
Spinal Cancer: Guidelines For Diagnosis Unsupported In Patients With Lower Back Pain
Feb 28, 2013
A new systematic review published in The Cochrane Library has raised doubts as to the effectiveness of "red flag" indicators at both identifying and excluding cancer in patients with lower back pain. The authors of the review concluded that most individual red flags were poor at diagnosing spinal malignancies and call for further studies focused on combinations of red flags... Read More
Screening Decisions Are Better Informed When Risk Information Is Personalised
Feb 28, 2013
Patients' ability to make genuinely informed choices about undergoing disease screening increases when the risk information that they receive is related to their own personal risk, rather than average risks, according to the results of a Cochrane systematic review. The authors reviewed data from studies, largely on cancer screens, in which patients were provided with personalised risk estimates... Read More
Breast Cancer Stem Cells Express HER2, Even In 'Negative' Tumors, Study Finds
Feb 28, 2013
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread... Read More
Medical Students And Residents Have Frequent Interactions With Pharmaceutical Companies, Survey Reveals
Feb 28, 2013
A first-of-its kind national survey of medical students and residents finds that despite recent efforts by medical schools and academic medical centers to restrict access of pharmaceutical sales representatives to medical trainees, medical students and residents still commonly receive meals, gifts, and industry-sponsored educational materials... Read More
Targeting Lung And Colon Cancers And Glioblastoma Using New Photon-Counting Technique
Feb 28, 2013
For scientists to improve cancer treatments with targeted therapeutic drugs, they need to be able to see proteins prevalent in the cancer cells. This has been impossible, until now. Thanks to a new microscopy technique, University of Akron researcher Dr... Read More
Breast Cancer Stem Cells Express HER2, Even In 'Negative' Tumors, Study Finds
Feb 28, 2013
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread... Read More
Breast Cancer Rates Increase Among Young Women
Feb 27, 2013
There has been a small increase in the incidence of advanced stage breast cancer among women 25 to 39 years old, according to a recent study in JAMA. Breast cancer is the most common form of malignant tumor in women aged 15 to 39 and accounts for nearly 14% of all cancer cases in men and women in that age group... Read More
Promising Viral Treatment For Prostate Cancer Without Unpleasant Side Effects
Feb 27, 2013
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of Virology... Read More
Patients' Fear Of Developing Lymphedema Far Exceeds Risk Following Breast Cancer Treatment
Feb 27, 2013
Women who have had the lymph nodes under their arm surgically removed during breast cancer treatment are warned to avoid certain practices that can cause lymphedema - a condition that causes chronic, painless swelling in the arm... Read More
Iron Intake May Help To Protect Women Against PMS
Feb 27, 2013
Women who reported eating a diet rich in iron were 30 to 40 percent less likely to develop pre-menstrual syndrome (PMS) than women who consumed lower amounts, in a study reported this week by researchers at the University of Massachusetts Amherst School of Public Health and Health Sciences and Harvard... Read More
Previous Page Next Page